Knight Therapeutics | GUD - 资产

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 992.48M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	资产	更改		日
Acasti Pharma	USD 68.49M		1.91M	2025-12
Akebia Therapeutics	USD 362.52M		14.04M	2026-03
Alaunos Therapeutics	USD 1.88M		1.08M	2026-03
Aurora Cannabis	CAD 601.09M		174.2M	2026-03
Avita Medical	AUD 56.39M		1.74M	2025-12
Canopy Growth	CAD 1.12B		12.54M	2026-03
Cronos Group	USD 1.17B		25.03M	2026-03
Dianthus Therapeutics	USD 1.25B		715.96M	2026-03
Ionis Pharmaceuticals	USD 3.45B		74M	2026-03
IQVIA Holdings	USD 29.68B		269M	2026-03
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Moderna	USD 11.49B		850M	2026-03
Omeros	USD 200.57M		34.59M	2025-06
Organigram Holdings	CAD 521.31M		9.36M	2026-03
Organon & Co	USD 13B		129M	2026-03
Revvity	USD 12B		171.82M	2026-03
Tectonic Therapeutic	USD 246.58M		14.46M	2026-03
Tilray	USD 2.1B		15.95M	2025-09
Viatris	USD 36.83B		358.5M	2026-03
Xeris Pharmaceuticals	USD 392.01M		8.49M	2026-03